Piezo Therapeutics aims to transform the delivery of nucleic acid medicines to enable improved safety, affordability, and scalability. Piezo is developing a uniquely engineered platform that uses electric pulses and microneedles to deliver a broad range of therapeutics inside the body. Its piezoelectric technology offers improved safety and efficacy, and is simple, cost-effective, and rapid to produce at scale. Founded by experts in the field of drug delivery and commercial translation, Piezo’s diverse team aims to help translate the next generation of nucleic acid medicines. For more information, please visit www.piezotx.com or email partnerships@piezotx.com.
Location: United States, Georgia, Atlanta
Employees: 1-10
Total raised: $2M
Investors 1
| Date | Name | Website |
| - | Georgia Re... | gra.org |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 18.01.2023 | Seed | $2M | - |
Mentions in press and media 2
| Date | Title | Description |
| 19.01.2023 | Piezo Therapeutics Launches to Transform Delivery of Nucleic Acid Medicines | Piezo Therapeutics is advancing a novel delivery platform to improve the safety, affordability, and scalability of nucleic acid medicines. ATLANTA (PRWEB) January 19, 2023 Piezo Therapeutics launched with $2 million in seed funding from Ope... |
| - | Piezo Therapeutics | “PiezoTx” |